| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Iran | 153 | 2024 | 763 | 16.030 |
Why?
|
| Quality-Adjusted Life Years | 61 | 2024 | 1741 | 4.950 |
Why?
|
| Accidents, Traffic | 8 | 2023 | 819 | 3.600 |
Why?
|
| Sodium Chloride, Dietary | 6 | 2021 | 301 | 3.230 |
Why?
|
| Automobile Driving | 6 | 2023 | 442 | 3.120 |
Why?
|
| Cost of Illness | 21 | 2023 | 1960 | 2.670 |
Why?
|
| Prevalence | 72 | 2024 | 15879 | 2.570 |
Why?
|
| Disabled Persons | 10 | 2024 | 1210 | 2.330 |
Why?
|
| Child Mortality | 7 | 2023 | 204 | 2.280 |
Why?
|
| Life Expectancy | 15 | 2024 | 1249 | 2.250 |
Why?
|
| Hypertension | 21 | 2024 | 8617 | 2.090 |
Why?
|
| Incidence | 53 | 2024 | 21547 | 1.960 |
Why?
|
| Diabetes Mellitus | 23 | 2024 | 5892 | 1.960 |
Why?
|
| Overweight | 9 | 2024 | 2448 | 1.850 |
Why?
|
| Quality of Health Care | 20 | 2024 | 4339 | 1.790 |
Why?
|
| Health Surveys | 18 | 2022 | 4055 | 1.770 |
Why?
|
| Tobacco Smoke Pollution | 4 | 2023 | 828 | 1.640 |
Why?
|
| Infant Mortality | 5 | 2023 | 754 | 1.590 |
Why?
|
| Wounds and Injuries | 13 | 2021 | 2517 | 1.490 |
Why?
|
| Hypercholesterolemia | 7 | 2023 | 1145 | 1.470 |
Why?
|
| Middle East | 14 | 2024 | 233 | 1.450 |
Why?
|
| Male | 170 | 2024 | 365203 | 1.430 |
Why?
|
| Risk Factors | 78 | 2024 | 74976 | 1.400 |
Why?
|
| Age Distribution | 23 | 2024 | 2875 | 1.360 |
Why?
|
| Humans | 267 | 2024 | 768970 | 1.350 |
Why?
|
| Endocarditis | 3 | 2024 | 352 | 1.340 |
Why?
|
| Myocardial Ischemia | 5 | 2024 | 2139 | 1.320 |
Why?
|
| Sex Distribution | 20 | 2024 | 2280 | 1.310 |
Why?
|
| Female | 171 | 2024 | 397515 | 1.300 |
Why?
|
| Africa, Northern | 10 | 2024 | 86 | 1.290 |
Why?
|
| Epidemiologic Research Design | 15 | 2014 | 368 | 1.290 |
Why?
|
| Dental Caries | 2 | 2023 | 429 | 1.280 |
Why?
|
| Obesity | 16 | 2024 | 13091 | 1.220 |
Why?
|
| Cardiovascular Diseases | 26 | 2024 | 15661 | 1.170 |
Why?
|
| Stomach Neoplasms | 7 | 2023 | 1483 | 1.160 |
Why?
|
| Developing Countries | 21 | 2024 | 2911 | 1.140 |
Why?
|
| Pyrenes | 2 | 2024 | 51 | 1.120 |
Why?
|
| Prediabetic State | 2 | 2023 | 548 | 1.110 |
Why?
|
| Feeding Behavior | 7 | 2023 | 3205 | 1.090 |
Why?
|
| Hepatitis C | 3 | 2022 | 1595 | 1.090 |
Why?
|
| Particulate Matter | 7 | 2024 | 2615 | 1.090 |
Why?
|
| Air Pollution, Indoor | 2 | 2024 | 931 | 1.070 |
Why?
|
| Cross-Sectional Studies | 42 | 2024 | 26395 | 1.050 |
Why?
|
| Adult | 113 | 2024 | 223851 | 1.050 |
Why?
|
| Air Pollutants | 5 | 2024 | 2915 | 1.030 |
Why?
|
| Mortality | 16 | 2021 | 2914 | 1.030 |
Why?
|
| Antihypertensive Agents | 7 | 2023 | 2027 | 0.990 |
Why?
|
| Exercise | 5 | 2023 | 5954 | 0.970 |
Why?
|
| Bayes Theorem | 19 | 2024 | 2360 | 0.970 |
Why?
|
| Epidemiology | 4 | 2017 | 278 | 0.950 |
Why?
|
| Unionidae | 1 | 2024 | 1 | 0.940 |
Why?
|
| Physicians, Family | 2 | 2017 | 349 | 0.940 |
Why?
|
| Registries | 15 | 2021 | 8384 | 0.930 |
Why?
|
| Socioeconomic Factors | 21 | 2023 | 7861 | 0.920 |
Why?
|
| Hepatitis B | 2 | 2020 | 711 | 0.880 |
Why?
|
| Rural Population | 8 | 2023 | 2325 | 0.880 |
Why?
|
| Automobiles | 2 | 2021 | 103 | 0.860 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2022 | 930 | 0.860 |
Why?
|
| Environmental Exposure | 7 | 2024 | 4544 | 0.860 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2022 | 3253 | 0.850 |
Why?
|
| Aged | 82 | 2024 | 171786 | 0.840 |
Why?
|
| Tooth, Deciduous | 1 | 2022 | 76 | 0.820 |
Why?
|
| Young Adult | 50 | 2024 | 60131 | 0.790 |
Why?
|
| Middle Aged | 92 | 2024 | 223737 | 0.790 |
Why?
|
| Head Protective Devices | 2 | 2021 | 118 | 0.780 |
Why?
|
| Tooth Loss | 1 | 2023 | 200 | 0.760 |
Why?
|
| Mercury | 1 | 2024 | 289 | 0.750 |
Why?
|
| Income | 9 | 2022 | 1879 | 0.740 |
Why?
|
| Breast Neoplasms, Male | 1 | 2023 | 212 | 0.740 |
Why?
|
| Polypharmacy | 1 | 2024 | 307 | 0.730 |
Why?
|
| Cities | 3 | 2024 | 543 | 0.730 |
Why?
|
| Peptic Ulcer | 1 | 2022 | 215 | 0.730 |
Why?
|
| Rural Health Services | 2 | 2017 | 394 | 0.720 |
Why?
|
| Cause of Death | 13 | 2021 | 3721 | 0.720 |
Why?
|
| Blood Pressure | 13 | 2023 | 8544 | 0.700 |
Why?
|
| Hypertriglyceridemia | 1 | 2023 | 293 | 0.700 |
Why?
|
| Maternal Mortality | 2 | 2021 | 310 | 0.680 |
Why?
|
| Economics | 1 | 2020 | 141 | 0.680 |
Why?
|
| Seat Belts | 1 | 2019 | 60 | 0.660 |
Why?
|
| Metals, Heavy | 1 | 2021 | 149 | 0.660 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2023 | 411 | 0.650 |
Why?
|
| Respiration Disorders | 1 | 2022 | 365 | 0.650 |
Why?
|
| Models, Statistical | 13 | 2021 | 5110 | 0.650 |
Why?
|
| Body Mass Index | 16 | 2022 | 13055 | 0.630 |
Why?
|
| Health Policy | 4 | 2023 | 2700 | 0.610 |
Why?
|
| Adolescent | 45 | 2024 | 89244 | 0.610 |
Why?
|
| Infant, Newborn | 27 | 2024 | 26428 | 0.600 |
Why?
|
| Asthma | 6 | 2022 | 6293 | 0.600 |
Why?
|
| Health Status | 7 | 2024 | 4095 | 0.590 |
Why?
|
| Pesticides | 1 | 2021 | 298 | 0.590 |
Why?
|
| Insulin Infusion Systems | 1 | 2019 | 221 | 0.590 |
Why?
|
| Helicobacter Infections | 2 | 2021 | 390 | 0.590 |
Why?
|
| Bibliometrics | 1 | 2021 | 355 | 0.580 |
Why?
|
| Goals | 3 | 2019 | 717 | 0.570 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 380 | 0.570 |
Why?
|
| Vital Statistics | 1 | 2017 | 31 | 0.550 |
Why?
|
| Transportation | 1 | 2018 | 217 | 0.550 |
Why?
|
| Stroke | 7 | 2022 | 9756 | 0.540 |
Why?
|
| Public Health | 6 | 2021 | 2680 | 0.520 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 4363 | 0.510 |
Why?
|
| Population Surveillance | 4 | 2020 | 2597 | 0.500 |
Why?
|
| Data Collection | 3 | 2022 | 3324 | 0.490 |
Why?
|
| Government Programs | 1 | 2017 | 278 | 0.480 |
Why?
|
| Genital Neoplasms, Female | 1 | 2020 | 538 | 0.480 |
Why?
|
| Environmental Monitoring | 4 | 2024 | 1469 | 0.480 |
Why?
|
| Commerce | 1 | 2020 | 613 | 0.470 |
Why?
|
| Urologic Neoplasms | 1 | 2018 | 318 | 0.470 |
Why?
|
| Heart Valve Diseases | 1 | 2022 | 1030 | 0.460 |
Why?
|
| Midwifery | 1 | 2016 | 131 | 0.460 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 1399 | 0.460 |
Why?
|
| Infant | 25 | 2024 | 36556 | 0.460 |
Why?
|
| Child, Preschool | 27 | 2024 | 42683 | 0.460 |
Why?
|
| Leukemia | 1 | 2022 | 1520 | 0.450 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2024 | 2044 | 0.450 |
Why?
|
| Life Style | 5 | 2024 | 3931 | 0.450 |
Why?
|
| Environmental Illness | 1 | 2014 | 33 | 0.450 |
Why?
|
| Disability Evaluation | 3 | 2019 | 1839 | 0.450 |
Why?
|
| Safety | 1 | 2018 | 1161 | 0.450 |
Why?
|
| Program Development | 1 | 2020 | 1300 | 0.440 |
Why?
|
| Air Pollution | 4 | 2023 | 2372 | 0.440 |
Why?
|
| Social Class | 6 | 2022 | 2009 | 0.440 |
Why?
|
| Feedback | 3 | 2023 | 799 | 0.440 |
Why?
|
| Earthquakes | 1 | 2016 | 192 | 0.430 |
Why?
|
| DMF Index | 2 | 2023 | 87 | 0.430 |
Why?
|
| Sodium | 1 | 2018 | 1597 | 0.430 |
Why?
|
| Motivation | 1 | 2023 | 2025 | 0.430 |
Why?
|
| Diabetes, Gestational | 4 | 2023 | 1263 | 0.420 |
Why?
|
| Neoplasms | 8 | 2022 | 22389 | 0.420 |
Why?
|
| Aged, 80 and over | 31 | 2024 | 59739 | 0.420 |
Why?
|
| Nutritional Status | 2 | 2021 | 1627 | 0.420 |
Why?
|
| Alcohol Drinking | 3 | 2024 | 4045 | 0.410 |
Why?
|
| Research Design | 5 | 2018 | 6214 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 4056 | 0.410 |
Why?
|
| National Health Programs | 1 | 2016 | 442 | 0.410 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2024 | 2297 | 0.410 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2022 | 2251 | 0.410 |
Why?
|
| Liver Cirrhosis | 2 | 2022 | 1962 | 0.400 |
Why?
|
| Health Status Disparities | 5 | 2021 | 1886 | 0.400 |
Why?
|
| Multilevel Analysis | 5 | 2014 | 148 | 0.400 |
Why?
|
| Child | 31 | 2024 | 80960 | 0.390 |
Why?
|
| Metabolome | 2 | 2019 | 1009 | 0.390 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2024 | 12253 | 0.390 |
Why?
|
| Awareness | 1 | 2016 | 653 | 0.380 |
Why?
|
| Regression Analysis | 9 | 2021 | 6346 | 0.380 |
Why?
|
| Medical Records | 2 | 2014 | 1411 | 0.370 |
Why?
|
| World Health Organization | 4 | 2023 | 1328 | 0.370 |
Why?
|
| Oral Health | 3 | 2023 | 493 | 0.360 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 3447 | 0.360 |
Why?
|
| History, 20th Century | 4 | 2020 | 2771 | 0.360 |
Why?
|
| Arsenic | 2 | 2024 | 358 | 0.350 |
Why?
|
| History, 21st Century | 4 | 2020 | 1575 | 0.350 |
Why?
|
| Disasters | 1 | 2016 | 522 | 0.340 |
Why?
|
| Primary Health Care | 5 | 2021 | 4748 | 0.340 |
Why?
|
| Policy Making | 1 | 2014 | 546 | 0.340 |
Why?
|
| Multiple Sclerosis | 2 | 2023 | 3250 | 0.340 |
Why?
|
| Vitamins | 1 | 2018 | 1638 | 0.340 |
Why?
|
| Cesarean Section | 3 | 2023 | 1426 | 0.330 |
Why?
|
| Metals | 2 | 2024 | 713 | 0.330 |
Why?
|
| Osteoporosis | 3 | 2024 | 1606 | 0.330 |
Why?
|
| Cholesterol | 6 | 2022 | 2913 | 0.320 |
Why?
|
| Fraud | 2 | 2020 | 66 | 0.320 |
Why?
|
| Photography | 2 | 2022 | 537 | 0.310 |
Why?
|
| Mental Disorders | 2 | 2022 | 6876 | 0.310 |
Why?
|
| Smoking Cessation | 1 | 2020 | 2085 | 0.300 |
Why?
|
| Sarcopenia | 2 | 2024 | 377 | 0.300 |
Why?
|
| Smoking | 6 | 2021 | 9094 | 0.300 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2336 | 0.300 |
Why?
|
| Lead | 2 | 2024 | 882 | 0.300 |
Why?
|
| Amino Acids | 4 | 2023 | 1716 | 0.300 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 13594 | 0.300 |
Why?
|
| Blood Glucose | 9 | 2023 | 6435 | 0.290 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 5522 | 0.290 |
Why?
|
| Kidney | 1 | 2023 | 7058 | 0.290 |
Why?
|
| Vision Disorders | 1 | 2014 | 1093 | 0.280 |
Why?
|
| Lipids | 1 | 2018 | 3345 | 0.280 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 4300 | 0.280 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 4919 | 0.270 |
Why?
|
| Sex Factors | 12 | 2021 | 10633 | 0.270 |
Why?
|
| Aspirin | 4 | 2024 | 3135 | 0.270 |
Why?
|
| Databases, Factual | 10 | 2021 | 8094 | 0.270 |
Why?
|
| Time Factors | 15 | 2021 | 40261 | 0.270 |
Why?
|
| Reference Values | 2 | 2024 | 4940 | 0.270 |
Why?
|
| Risk Assessment | 14 | 2023 | 24333 | 0.260 |
Why?
|
| Dyslipidemias | 1 | 2014 | 873 | 0.260 |
Why?
|
| Markov Chains | 5 | 2020 | 979 | 0.260 |
Why?
|
| Bipolar Disorder | 1 | 2023 | 5131 | 0.260 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 453 | 0.260 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 1407 | 0.260 |
Why?
|
| Age Factors | 13 | 2021 | 18435 | 0.250 |
Why?
|
| Hospitals | 2 | 2021 | 3904 | 0.240 |
Why?
|
| Demography | 3 | 2021 | 1642 | 0.240 |
Why?
|
| Computer Simulation | 1 | 2018 | 6291 | 0.240 |
Why?
|
| Insulin | 1 | 2019 | 6610 | 0.240 |
Why?
|
| Pyridoxine | 1 | 2024 | 109 | 0.230 |
Why?
|
| Vitamin D | 1 | 2018 | 3311 | 0.230 |
Why?
|
| Health Promotion | 1 | 2016 | 2210 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 2 | 2021 | 5443 | 0.230 |
Why?
|
| Carnitine | 3 | 2022 | 253 | 0.230 |
Why?
|
| Projection | 1 | 2023 | 18 | 0.220 |
Why?
|
| Prescriptions | 2 | 2024 | 388 | 0.220 |
Why?
|
| Dentition, Permanent | 1 | 2023 | 22 | 0.220 |
Why?
|
| Healthcare Disparities | 3 | 2020 | 3421 | 0.220 |
Why?
|
| Geography | 3 | 2021 | 654 | 0.220 |
Why?
|
| Aluminum | 1 | 2024 | 150 | 0.220 |
Why?
|
| Nickel | 1 | 2024 | 126 | 0.220 |
Why?
|
| Chromium | 1 | 2024 | 133 | 0.220 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2024 | 354 | 0.210 |
Why?
|
| Tunisia | 1 | 2022 | 36 | 0.210 |
Why?
|
| Substance-Related Disorders | 2 | 2024 | 4423 | 0.210 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 3238 | 0.210 |
Why?
|
| Alkaloids | 1 | 2024 | 192 | 0.210 |
Why?
|
| Cadmium | 1 | 2024 | 217 | 0.210 |
Why?
|
| Toothbrushing | 1 | 2022 | 47 | 0.210 |
Why?
|
| Lebanon | 1 | 2023 | 245 | 0.200 |
Why?
|
| Risk Reduction Behavior | 2 | 2019 | 1119 | 0.200 |
Why?
|
| Chronic Disease | 2 | 2015 | 9384 | 0.200 |
Why?
|
| Niacinamide | 1 | 2024 | 418 | 0.200 |
Why?
|
| Fetal Macrosomia | 4 | 2023 | 138 | 0.200 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 6982 | 0.200 |
Why?
|
| Clinical Protocols | 4 | 2014 | 1445 | 0.200 |
Why?
|
| Pandemics | 4 | 2022 | 8749 | 0.190 |
Why?
|
| Data Mining | 2 | 2018 | 563 | 0.190 |
Why?
|
| Calcium, Dietary | 1 | 2024 | 533 | 0.190 |
Why?
|
| Disease Outbreaks | 2 | 2014 | 1761 | 0.190 |
Why?
|
| Tobacco, Smokeless | 1 | 2022 | 133 | 0.190 |
Why?
|
| PubMed | 1 | 2021 | 130 | 0.180 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 2974 | 0.180 |
Why?
|
| Rheumatic Heart Disease | 1 | 2022 | 164 | 0.180 |
Why?
|
| Sampling Studies | 1 | 2022 | 615 | 0.180 |
Why?
|
| Insulin Resistance | 3 | 2022 | 3982 | 0.180 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5864 | 0.180 |
Why?
|
| Premature Birth | 2 | 2023 | 1830 | 0.180 |
Why?
|
| Pregnancy in Diabetics | 1 | 2022 | 198 | 0.180 |
Why?
|
| Metabolomics | 5 | 2023 | 1675 | 0.180 |
Why?
|
| Gallbladder | 1 | 2021 | 308 | 0.170 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2023 | 268 | 0.170 |
Why?
|
| Child, Hospitalized | 1 | 2021 | 182 | 0.170 |
Why?
|
| Lip | 1 | 2021 | 197 | 0.170 |
Why?
|
| Health Transition | 2 | 2019 | 35 | 0.170 |
Why?
|
| Poverty Areas | 1 | 2021 | 269 | 0.160 |
Why?
|
| Ozone | 1 | 2023 | 496 | 0.160 |
Why?
|
| Urban Population | 3 | 2022 | 2046 | 0.160 |
Why?
|
| Housing | 1 | 2024 | 683 | 0.160 |
Why?
|
| History of Medicine | 1 | 2019 | 42 | 0.160 |
Why?
|
| Sphingomyelins | 1 | 2019 | 105 | 0.160 |
Why?
|
| Systole | 1 | 2021 | 937 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2010 | 1542 | 0.150 |
Why?
|
| Mediterranean Region | 4 | 2019 | 47 | 0.150 |
Why?
|
| Telecommunications | 1 | 2018 | 79 | 0.150 |
Why?
|
| Mitral Valve Prolapse | 1 | 2020 | 213 | 0.150 |
Why?
|
| Thyroid Neoplasms | 2 | 2022 | 2360 | 0.150 |
Why?
|
| Diet | 3 | 2023 | 8088 | 0.150 |
Why?
|
| Fruit | 1 | 2023 | 1165 | 0.150 |
Why?
|
| Insurance, Health | 3 | 2020 | 2518 | 0.150 |
Why?
|
| Hypothyroidism | 1 | 2023 | 667 | 0.150 |
Why?
|
| Taxes | 1 | 2020 | 220 | 0.150 |
Why?
|
| Australia | 1 | 2021 | 1265 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 21188 | 0.150 |
Why?
|
| Policy | 1 | 2021 | 514 | 0.140 |
Why?
|
| Monte Carlo Method | 4 | 2020 | 1262 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2019 | 406 | 0.140 |
Why?
|
| Aging | 4 | 2024 | 8745 | 0.140 |
Why?
|
| Death Certificates | 1 | 2018 | 172 | 0.140 |
Why?
|
| Magnetite Nanoparticles | 1 | 2019 | 313 | 0.140 |
Why?
|
| Japan | 1 | 2021 | 1418 | 0.140 |
Why?
|
| Secondary Prevention | 1 | 2023 | 1476 | 0.140 |
Why?
|
| Anthropometry | 1 | 2022 | 1345 | 0.140 |
Why?
|
| State Health Plans | 1 | 2019 | 220 | 0.140 |
Why?
|
| Health Services | 1 | 2022 | 755 | 0.140 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 587 | 0.140 |
Why?
|
| Peer Group | 1 | 2022 | 698 | 0.140 |
Why?
|
| Lysophospholipids | 1 | 2019 | 338 | 0.140 |
Why?
|
| Pregnancy | 10 | 2023 | 30265 | 0.130 |
Why?
|
| Visually Impaired Persons | 1 | 2017 | 79 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2024 | 1187 | 0.130 |
Why?
|
| Headache Disorders | 1 | 2019 | 152 | 0.130 |
Why?
|
| Urinalysis | 1 | 2018 | 370 | 0.130 |
Why?
|
| Reference Standards | 1 | 2020 | 1014 | 0.130 |
Why?
|
| Nitrogen Dioxide | 1 | 2019 | 534 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3253 | 0.130 |
Why?
|
| Blood Pressure Determination | 1 | 2020 | 646 | 0.130 |
Why?
|
| Social Problems | 1 | 2016 | 108 | 0.130 |
Why?
|
| Censuses | 1 | 2017 | 198 | 0.130 |
Why?
|
| Forecasting | 2 | 2022 | 2945 | 0.130 |
Why?
|
| Survival Rate | 3 | 2019 | 12873 | 0.130 |
Why?
|
| Regeneration | 1 | 2024 | 1524 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 2 | 2014 | 1204 | 0.130 |
Why?
|
| Homicide | 1 | 2018 | 294 | 0.130 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 577 | 0.130 |
Why?
|
| Achievement | 1 | 2017 | 288 | 0.120 |
Why?
|
| Central Nervous System | 1 | 2022 | 1346 | 0.120 |
Why?
|
| Vision, Low | 1 | 2017 | 162 | 0.120 |
Why?
|
| Developed Countries | 3 | 2023 | 452 | 0.120 |
Why?
|
| Bronchitis, Chronic | 1 | 2016 | 82 | 0.120 |
Why?
|
| Neck Pain | 1 | 2017 | 191 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2022 | 1197 | 0.120 |
Why?
|
| Phenols | 1 | 2019 | 526 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2021 | 1320 | 0.120 |
Why?
|
| Task Performance and Analysis | 1 | 2018 | 771 | 0.120 |
Why?
|
| Self Report | 3 | 2023 | 3773 | 0.120 |
Why?
|
| Family Practice | 1 | 2017 | 509 | 0.120 |
Why?
|
| Fast Foods | 1 | 2016 | 220 | 0.110 |
Why?
|
| Publishing | 1 | 2021 | 837 | 0.110 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2022 | 2203 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 2403 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2020 | 957 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2023 | 1296 | 0.110 |
Why?
|
| Food Labeling | 1 | 2016 | 181 | 0.110 |
Why?
|
| Opium | 1 | 2013 | 28 | 0.110 |
Why?
|
| Stress, Mechanical | 1 | 2019 | 1680 | 0.110 |
Why?
|
| Dental Health Services | 1 | 2013 | 48 | 0.110 |
Why?
|
| Pre-Eclampsia | 1 | 2023 | 1255 | 0.110 |
Why?
|
| Normal Distribution | 1 | 2014 | 272 | 0.110 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 1738 | 0.110 |
Why?
|
| Chromatography, Liquid | 3 | 2022 | 997 | 0.110 |
Why?
|
| China | 1 | 2019 | 2395 | 0.110 |
Why?
|
| Blindness | 1 | 2017 | 587 | 0.110 |
Why?
|
| Dementia | 3 | 2019 | 2741 | 0.110 |
Why?
|
| Diarrhea | 2 | 2016 | 1320 | 0.100 |
Why?
|
| Review Literature as Topic | 1 | 2014 | 298 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2019 | 808 | 0.100 |
Why?
|
| Decision Trees | 1 | 2014 | 509 | 0.100 |
Why?
|
| Diuretics | 1 | 2016 | 614 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 948 | 0.100 |
Why?
|
| Prisons | 1 | 2014 | 179 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 4978 | 0.100 |
Why?
|
| Calcium Channel Blockers | 1 | 2016 | 691 | 0.100 |
Why?
|
| Bone Density | 2 | 2022 | 3574 | 0.100 |
Why?
|
| Urbanization | 1 | 2013 | 100 | 0.100 |
Why?
|
| Wounds, Gunshot | 1 | 2018 | 588 | 0.100 |
Why?
|
| HIV Infections | 5 | 2022 | 17591 | 0.100 |
Why?
|
| Health Behavior | 2 | 2021 | 2649 | 0.100 |
Why?
|
| Benzhydryl Compounds | 1 | 2019 | 944 | 0.100 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 658 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2019 | 774 | 0.100 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2014 | 348 | 0.100 |
Why?
|
| Pregnancy Outcome | 4 | 2023 | 2974 | 0.100 |
Why?
|
| Survival Analysis | 3 | 2020 | 10115 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2016 | 1514 | 0.100 |
Why?
|
| Mouth Diseases | 1 | 2014 | 239 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 1014 | 0.100 |
Why?
|
| Narcotics | 1 | 2013 | 332 | 0.090 |
Why?
|
| Prescription Drugs | 1 | 2018 | 635 | 0.090 |
Why?
|
| Calcinosis | 1 | 2020 | 1479 | 0.090 |
Why?
|
| Vitamin E | 1 | 2015 | 874 | 0.090 |
Why?
|
| Logistic Models | 3 | 2022 | 13318 | 0.090 |
Why?
|
| International Classification of Diseases | 1 | 2017 | 936 | 0.090 |
Why?
|
| Health Care Reform | 1 | 2020 | 1262 | 0.090 |
Why?
|
| Firearms | 1 | 2018 | 632 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2020 | 1673 | 0.090 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 5375 | 0.090 |
Why?
|
| Equipment Design | 1 | 2018 | 3530 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2022 | 22296 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 1415 | 0.090 |
Why?
|
| Prognosis | 3 | 2021 | 30046 | 0.090 |
Why?
|
| Research | 1 | 2018 | 1981 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2022 | 3235 | 0.090 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 1243 | 0.090 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2014 | 530 | 0.090 |
Why?
|
| Aortic Valve | 1 | 2020 | 1969 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1094 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2015 | 744 | 0.080 |
Why?
|
| Glucose Tolerance Test | 2 | 2023 | 1183 | 0.080 |
Why?
|
| Psychiatry | 1 | 2022 | 1716 | 0.080 |
Why?
|
| Gout | 1 | 2017 | 621 | 0.080 |
Why?
|
| Education, Medical | 1 | 2021 | 1742 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 1364 | 0.080 |
Why?
|
| DNA Damage | 1 | 2019 | 2472 | 0.080 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 1064 | 0.080 |
Why?
|
| Osteoarthritis | 1 | 2017 | 1070 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 684 | 0.080 |
Why?
|
| Comorbidity | 2 | 2023 | 10592 | 0.080 |
Why?
|
| Program Evaluation | 1 | 2017 | 2508 | 0.080 |
Why?
|
| Low Back Pain | 1 | 2017 | 990 | 0.080 |
Why?
|
| Organizational Objectives | 3 | 2014 | 426 | 0.070 |
Why?
|
| Preventive Health Services | 1 | 2013 | 570 | 0.070 |
Why?
|
| Antioxidants | 1 | 2015 | 1673 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 2034 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2023 | 81903 | 0.070 |
Why?
|
| Suicide | 1 | 2018 | 1606 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2015 | 1458 | 0.070 |
Why?
|
| Health Resources | 1 | 2013 | 951 | 0.070 |
Why?
|
| International Cooperation | 1 | 2013 | 1436 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2015 | 873 | 0.070 |
Why?
|
| Nutrition Policy | 1 | 2011 | 467 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2013 | 985 | 0.070 |
Why?
|
| Vaccination | 1 | 2019 | 3438 | 0.070 |
Why?
|
| Universities | 2 | 2022 | 1005 | 0.070 |
Why?
|
| Fasting | 3 | 2023 | 1610 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2021 | 3463 | 0.060 |
Why?
|
| Poverty | 3 | 2022 | 2720 | 0.060 |
Why?
|
| DNA | 1 | 2019 | 7214 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2014 | 1305 | 0.060 |
Why?
|
| Morbidity | 2 | 2020 | 1757 | 0.060 |
Why?
|
| Malaria | 1 | 2014 | 1249 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2019 | 65480 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2022 | 4818 | 0.060 |
Why?
|
| Risk | 2 | 2013 | 9621 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12467 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 20245 | 0.060 |
Why?
|
| Heroin | 1 | 2024 | 120 | 0.060 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 1926 | 0.050 |
Why?
|
| Phenotype | 2 | 2018 | 16731 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2016 | 2294 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2012 | 2080 | 0.050 |
Why?
|
| Models, Theoretical | 3 | 2021 | 3580 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2015 | 3443 | 0.050 |
Why?
|
| Methamphetamine | 1 | 2024 | 167 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2493 | 0.050 |
Why?
|
| Inpatients | 1 | 2014 | 2569 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 5176 | 0.050 |
Why?
|
| Physicians | 1 | 2020 | 4607 | 0.050 |
Why?
|
| Methadone | 1 | 2024 | 317 | 0.050 |
Why?
|
| Neglected Diseases | 1 | 2022 | 67 | 0.050 |
Why?
|
| Enalapril | 1 | 2023 | 317 | 0.050 |
Why?
|
| Algorithms | 2 | 2020 | 14201 | 0.050 |
Why?
|
| Africa | 2 | 2016 | 726 | 0.050 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2023 | 219 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2014 | 2029 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 3780 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 405 | 0.050 |
Why?
|
| Small-Area Analysis | 1 | 2021 | 51 | 0.050 |
Why?
|
| Educational Status | 2 | 2020 | 2515 | 0.050 |
Why?
|
| Animals | 5 | 2024 | 169335 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15951 | 0.050 |
Why?
|
| Space-Time Clustering | 1 | 2020 | 45 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 3913 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2022 | 753 | 0.040 |
Why?
|
| NAD | 1 | 2024 | 618 | 0.040 |
Why?
|
| Persia | 1 | 2019 | 7 | 0.040 |
Why?
|
| England | 1 | 2021 | 533 | 0.040 |
Why?
|
| Glycine | 1 | 2023 | 672 | 0.040 |
Why?
|
| Heart Failure | 2 | 2014 | 11879 | 0.040 |
Why?
|
| Linear Models | 2 | 2019 | 5891 | 0.040 |
Why?
|
| Dielectric Spectroscopy | 1 | 2019 | 32 | 0.040 |
Why?
|
| Palladium | 1 | 2019 | 67 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 12562 | 0.040 |
Why?
|
| History, Ancient | 1 | 2019 | 213 | 0.040 |
Why?
|
| Methylene Blue | 1 | 2019 | 156 | 0.040 |
Why?
|
| Gallbladder Neoplasms | 1 | 2020 | 190 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2023 | 917 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2019 | 95 | 0.040 |
Why?
|
| Nanotubes, Carbon | 1 | 2019 | 72 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 277 | 0.040 |
Why?
|
| Lysophosphatidylcholines | 1 | 2018 | 77 | 0.040 |
Why?
|
| Vegetables | 1 | 2023 | 1199 | 0.040 |
Why?
|
| Sample Size | 1 | 2021 | 848 | 0.040 |
Why?
|
| United States | 2 | 2023 | 73186 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2276 | 0.040 |
Why?
|
| Chitosan | 1 | 2019 | 141 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 395 | 0.040 |
Why?
|
| Djibouti | 1 | 2017 | 2 | 0.040 |
Why?
|
| Dimerization | 1 | 2019 | 886 | 0.040 |
Why?
|
| Cardiovascular Agents | 1 | 2023 | 849 | 0.030 |
Why?
|
| Somalia | 1 | 2017 | 78 | 0.030 |
Why?
|
| Depression | 1 | 2016 | 8231 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2019 | 8760 | 0.030 |
Why?
|
| Electrodes | 1 | 2019 | 617 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 1758 | 0.030 |
Why?
|
| Surface Properties | 1 | 2019 | 1169 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 27453 | 0.030 |
Why?
|
| Models, Biological | 1 | 2012 | 9499 | 0.030 |
Why?
|
| Uncertainty | 1 | 2020 | 769 | 0.030 |
Why?
|
| HIV | 1 | 2022 | 1597 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2024 | 54962 | 0.030 |
Why?
|
| Sanitation | 1 | 2015 | 83 | 0.030 |
Why?
|
| Marital Status | 1 | 2016 | 426 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2021 | 11262 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 406 | 0.030 |
Why?
|
| Disabled Children | 1 | 2017 | 250 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 1469 | 0.030 |
Why?
|
| Particle Size | 1 | 2019 | 1652 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5544 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2021 | 2732 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39394 | 0.030 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2015 | 153 | 0.030 |
Why?
|
| Gastritis, Atrophic | 1 | 2013 | 31 | 0.030 |
Why?
|
| Western World | 1 | 2013 | 27 | 0.030 |
Why?
|
| Social Perception | 1 | 2017 | 433 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1794 | 0.030 |
Why?
|
| Weight Gain | 1 | 2023 | 2359 | 0.030 |
Why?
|
| Cations | 1 | 2014 | 240 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2020 | 2437 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1913 | 0.030 |
Why?
|
| Thiazides | 1 | 2012 | 19 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 662 | 0.030 |
Why?
|
| Metaplasia | 1 | 2013 | 326 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 822 | 0.030 |
Why?
|
| Warfarin | 1 | 2021 | 1493 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 10400 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2024 | 2763 | 0.020 |
Why?
|
| Weight Loss | 1 | 2023 | 2721 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2015 | 638 | 0.020 |
Why?
|
| Eye Diseases | 1 | 2017 | 658 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 11521 | 0.020 |
Why?
|
| Rectal Neoplasms | 1 | 2020 | 1183 | 0.020 |
Why?
|
| Australasia | 1 | 2011 | 21 | 0.020 |
Why?
|
| Prisoners | 1 | 2014 | 316 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2019 | 1903 | 0.020 |
Why?
|
| Musculoskeletal Diseases | 1 | 2017 | 599 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 3629 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 41808 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2020 | 1674 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2015 | 971 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4352 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2014 | 1023 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2019 | 5404 | 0.020 |
Why?
|
| Epidemics | 1 | 2014 | 517 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2020 | 2543 | 0.020 |
Why?
|
| Hospitals, General | 1 | 2012 | 810 | 0.020 |
Why?
|
| North America | 1 | 2011 | 1290 | 0.020 |
Why?
|
| Mice | 2 | 2024 | 82072 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2024 | 11684 | 0.020 |
Why?
|
| Internationality | 1 | 2011 | 1008 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2021 | 4850 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2015 | 1807 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2019 | 2895 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 2714 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15471 | 0.010 |
Why?
|
| Europe | 1 | 2011 | 3441 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12095 | 0.010 |
Why?
|
| Homeostasis | 1 | 2014 | 3347 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 1812 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 6320 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 2190 | 0.010 |
Why?
|
| Coronary Disease | 1 | 2015 | 5919 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8748 | 0.010 |
Why?
|
| Length of Stay | 1 | 2012 | 6526 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 13510 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 8055 | 0.010 |
Why?
|